4
GenOn Notes Claims
In full and final satisfaction, compromise, settlement, release, and discharge of and in exchange for each GenOn Notes Claim, each Holder shall receive, subject to the charging lien of the GenOn Notes Trustee, its Pro Rata share of: (i) unless sold in its entirety pursuant to a Third-Party Sale Transaction, the New Common Stock, subject to dilution by any Management Incentive Plan; (ii) the GenOn Notes Cash Pool; (iii) as determined no later than the Effective Date by the Debtors in consultation with the GenOn Steering Committee, any New Subordinated Notes; (iv) the Subscription Rights; and (v) Cash in any amount due under the GenOn Notes Indentures to the GenOn Notes Trustee, and any applicable paying agent, on account of fees and expenses. On the Effective Date, all of the GenOn Notes shall be cancelled as set forth in Article IV.L of the Plan.
61.6–77.6%